4//SEC Filing
DEADY CONAN R 4
Accession 0001140361-13-008208
CIK 0000874716other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 7:23 PM ET
Size
38.7 KB
Accession
0001140361-13-008208
Insider Transaction Report
Form 4
DEADY CONAN R
Corp VP, General Counsel & Sec
Transactions
- Tax Payment
Common Stock
2013-02-14$91.68/sh−496$45,473→ 2,225 total - Exercise/Conversion
Restricted Stock Unit
2013-02-14−243→ 4,154 total→ Common Stock (243 underlying) - Exercise/Conversion
Common Stock
2013-02-14$34.37/sh+3,772$129,644→ 10,804 total - Exercise/Conversion
Common Stock
2013-02-14+375→ 2,058 total - Exercise/Conversion
Common Stock
2013-02-14$56.95/sh+3,449$196,421→ 4,631 total - Exercise/Conversion
Common Stock
2013-02-14$77.59/sh+2,401$186,294→ 7,032 total - Exercise/Conversion
Common Stock
2013-02-14+363→ 2,421 total - Exercise/Conversion
Restricted Stock Unit
2013-02-14−258→ 3,896 total→ Common Stock (258 underlying) - Sale
Common Stock
2013-02-14$92.04/sh−9,622$885,636→ 1,182 total - Exercise/Conversion
Common Stock
2013-02-14+243→ 1,425 total - Exercise/Conversion
Common Stock
2013-02-14+300→ 2,721 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2013-02-14−2,401→ 5,914 totalExercise: $77.59Exp: 2018-02-13→ Common Stock (2,401 underlying) - Exercise/Conversion
Common Stock
2013-02-14+258→ 1,683 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2013-02-14−1,693→ 0 totalExercise: $56.95Exp: 2015-02-13→ Common Stock (1,693 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2013-02-14−3,772→ 863 totalExercise: $34.37Exp: 2016-02-13→ Common Stock (3,772 underlying) - Exercise/Conversion
Incentive Stock Option (right to buy)
2013-02-14−1,756→ 0 totalExercise: $56.95Exp: 2015-02-13→ Common Stock (1,756 underlying) - Exercise/Conversion
Restricted Stock Unit
2013-02-14−375→ 3,521 total→ Common Stock (375 underlying) - Exercise/Conversion
Restricted Stock Unit
2013-02-14−300→ 2,858 total→ Common Stock (300 underlying) - Exercise/Conversion
Restricted Stock Unit
2013-02-14−363→ 3,158 total→ Common Stock (363 underlying)
Footnotes (10)
- [F1]The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $92.00 to $92.10, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- [F10]Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.
- [F2]Grant of options to buy shares of common stock becomes exercisable as to 3,449 shares on 02/14/2009 and 02/14/2010, 3,448 shares on 02/14/2011 and 02/14/2012, and the remaining 1,693 shares on 02/14/2013.
- [F3]Grant of options to buy shares of common stock becomes exercisable as to 2,401 shares on 02/14/2012, 02/14/2013, 02/14/2014 and 02/14/2015, and the remaining 1,112 shares on 02/14/2016.
- [F4]Grant of options to buy shares of common stock becomes exercisable as to 3,772 shares on 02/14/2010 and 02/14/2013, 3,773 shares on 02/14/2011 and 02/14/2012, and the remaining 863 shares on 02/14/2014.
- [F5]Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2011, and the remaining 1,755 shares on 02/14/2013.
- [F6]Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.
- [F7]Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.
- [F8]Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.
- [F9]Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.
Documents
Issuer
IDEXX LABORATORIES INC /DE
CIK 0000874716
Entity typeother
Related Parties
1- filerCIK 0001184151
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 7:23 PM ET
- Size
- 38.7 KB